Real‐world experience of using dupilumab and JAK inhibitors to manage pruritus in epidermolysis bullosa pruriginosa

MLA

Ping‐Chen Hou, et al. “Real‐world Experience of Using Dupilumab and JAK Inhibitors to Manage Pruritus in Epidermolysis Bullosa Pruriginosa.” Skin Health and Disease, vol. 4, no. 5, Oct. 2024. EBSCOhost, https://doi.org/10.1002/ski2.445.

APA

Ping‐Chen Hou, Wilson Aala Jr., Wei‐Ting Tu, John A. McGrath, & Chao‐Kai Hsu. (2024). Real‐world experience of using dupilumab and JAK inhibitors to manage pruritus in epidermolysis bullosa pruriginosa. Skin Health and Disease, 4(5). https://doi.org/10.1002/ski2.445

Chicago

Ping‐Chen Hou, Wilson Aala Jr., Wei‐Ting Tu, John A. McGrath, and Chao‐Kai Hsu. 2024. “Real‐world Experience of Using Dupilumab and JAK Inhibitors to Manage Pruritus in Epidermolysis Bullosa Pruriginosa.” Skin Health and Disease 4 (5). doi:10.1002/ski2.445.